Abstract:Background: Although the development of novel therapeutic regimens to combat hepatitis C virus (HCV) infection have been speeded up with successful results, no efficient vaccines exist yet. Objectives: This study aimed to construct a eukaryotic expression vector encoding nonstructural proteins, NS3/NS4A, of HCV genotype 3a, and evaluate its expression on Huh7 cell surface. Materials and methods: The NS3/NS4A sequence was isolated from a patient with HCV-3a chronic infection, cloned into intermediate vector pTZ57R/T, and then used for engineering a mammalian expression vector, pDisplay, to direct the respective protein to the secretory pathway and anchor it to the plasma membrane. The expression of the protein in Huh7 cell, which was transiently transfected with the vector using Lipofectamine, was determined by immunocytochemical staining assay with fluorescein isothiocyanate (FITC)-conjugated antibodies to the HA/myc tags located besides the fusion fragment. Results: The results showed that the fragment was successfully amplified and cloned into a eukaryotic expression vector. Sequencing and enzyme digestion analysis confirmed the cloned gene completion and its correct position in the pDisply-NS3/NS4A plasmid. Immunocytochemical staining revealed that the target protein was expressed as a membrane-anchored protein in the Huh7 cells. Conclusions: This study can serve as a fundamental experiment for the construction of a NS3/NS4A eukaryotic expression vector and its expression in mammalian cells. Further research is underway to evaluate the fragment immunogenicity in lab animal models.

Expression of Soluble Hepatitis C Virus NS3 Proteases in Pichia Pastoris

Expression of NS5ATP13 transregulated by HCV NS5A in Pichia pastoris

Development of A Cell-Based Assay for Monitoring Hepatitis C Virus Ns3/4a Protease Activity

Expression and Purification of HCVNS3/4A Protease in the E.coil

Establishment of stably transfected HepG2 cell line expressing HCV scNS4A/NS3 protease

Establishment of a Cell-Based Assay System for Hepatitis C Virus Serine Protease and Its Primary Applications

Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector

Inhibition of hepatitis C virus serine protease in living cells by RNA aptamers detected using fluorescent protein substrates

Conditional Inducible Triple-Transgenic Mouse Model For Rapid Real-Time Detection Of Hcv Ns3/4a Protease Activity

Establishment of a Tetracycline-Regulated Cell Line Expressing High HCV NS3/4A Serine Protease

Development of a System for Monitoring Specific Hepatitis C Virus NS3/4Aprotease Activity in Live Mice

Cloning and expression of full-length hepatitis C NS3 gene in Escherichia coli

Construction and expression of plasmids containing the truncated core protein of different quasispecies genotype 1b hepatitis C virus

Expression of Hepatitis C Virus Core Protein in E.coli and in Pichia pastoris

Expression and Characterization of A Recombinant Truncated Capsid Protein of Hepatitis E Virus in Pichia Pastoris

Generation of conditionally controlled transgenic mice expressing hepatitis C virus NS3/4A protease

Stimulation of Hepatitis C Virus (HCV) Nonstructural Protein 3 (NS3) Helicase Activity by the NS3 Protease Domain and by HCV RNA-dependent RNA Polymerase.

Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor

Production and characterization of monoclonal antibody specific for NS3 helicase of hepatitis C virus.

Cloning and Expression of Ns3 Cdna Fragment of Hcv Genome of Hebei Isolate in E-Coli

Establishment of Triple Transgenic Mice Conditionally Expressing Hepatitis C Virus NS3/4A Protease Simultaneously Controlled by Tet-on and Cre/loxP Systems